スピーカー
- Dr. Scott Laneman
Join Us I Booth 4
This year, we’ll be highlighting our capabilities in oligo-based production. Upstream, our solutions can handle synthesis, cleavage, deprotection, and clean chemical storage. Our downstream abilities include process monitoring and robust freeze/thaw solutions. You’ll be able to see product examples that include filtration, fluid management, particle characterization, and more. Our experts will be on hand to demonstrate how you can harness our ultra-pure processing abilities to bring your technology to the mass market.
Featured Presentation
Organophosphorus Process Strategies In Oligonucleotide Synthesis
September 6, 12:00 PM
Oligo-Based Therapeutics Track
Don’t miss this special Entegris session where will discuss how to use different process strategies to achieve target synthesis of complex molecules. Various orthogonal approaches to RNA therapeutic manufacturing have allowed market leaders to meet exacting targets in terms of their purity, yield, and specific performance goals. This presentation will dive into phosphorylation and phosphitylation process strategies for RNA production with specific examples that will provide actionable intelligence for your own workflows.
Speaker:
Dr. Scott Laneman - Director, Innovation, Specialty Chemicals and Engineered Materials, Entegris
Dr. Laneman has over 30 years of experience in synthesis and scale up of various air- and moisture-sensitive entities. These include organophosphorus, transition metal complexes, and main group chemistries. His work has as allowed several industries, including pharmaceuticals, semiconductors, and manufacturing, to utilize pure and effective chemistries and improve their more sensitive processes. Dr. Laneman received his Ph.D. from Louisiana State University.